| Announce Date | 11/03/2025 |
| EPS Normalized Actual | $0.53 (Miss by $-1.1) |
| EPS GAAP Actual | $0.53 (Miss by $-1.1) |
| Revenue Actual | $0.592458B |
| Revenue Surprise | Beat by $592.458M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0 |
| EPS GAAP Estimate | $0 |
| Revenue Estimate | $0.580206B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2028 | 0 | INF | 0 | 0 | 0 |
| Dec 2027 | 0 | INF | 0 | 0 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.54 | -1.17 | 0.592458B | 7.17% | -31.33M |
| FQ2 2025 (Jun 2025) | 1.17 | -0.54 | 0.659515B | 7.01% | 42.6M |
| FQ1 2025 (Mar 2025) | 1.05 | 0.08 | 0.58728B | 10.04% | 29.65M |
| FQ4 2024 (Dec 2024) | 1.21 | 1.21 | 0.647633B | 2.25% | 647.63M |
| FQ3 2024 (Sep 2024) | 1.04 | 1.04 | 0.549958B | 3.9% | 549.96M |
| FQ2 2024 (Jun 2024) | 2.162 | 2.162 | 0.61329B | 17.68% | 613.29M |
| FQ1 2024 (Mar 2024) | 0.72 | 0.72 | 0.528345B | 6.93% | 528.35M |
| FQ4 2023 (Dec 2023) | 2.38 | 2.38 | 0.633063B | 100% | 633.06M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0
Consensus Revenue Estimates
0.580206B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0 | -- | 0 | 0 | 0 |
| FQ3 2027 (Sep 2027) | 0 | -- | 0 | 0 | 0 |
| FQ2 2027 (Jun 2027) | 0 | -- | 0 | 0 | 0 |
| FQ1 2027 (Mar 2027) | 0 | -- | 0 | 0 | 0 |
| FQ4 2026 (Oct 2026) | 0 | -- | 0 | 0 | 1 |
| FQ3 2026 (Jul 2026) | 0 | -INF | 0 | 0 | 1 |
| FQ2 2026 (Jun 2026) | 0 | -INF | 0 | 0 | 1 |
| FQ1 2026 (Mar 2026) | 0 | -INF | 0 | 0 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.82B | -- | 0.8B | 0.85B | 3 |
| FQ3 2027 (Sep 2027) | 0.67B | -- | 0.65B | 0.69B | 3 |
| FQ2 2027 (Jun 2027) | 0.74B | -- | 0.72B | 0.76B | 3 |
| FQ1 2027 (Mar 2027) | 0.69B | -- | 0.68B | 0.72B | 3 |
| FQ4 2026 (Oct 2026) | 0.6B | -- | 0.59B | 0.61B | 2 |
| FQ3 2026 (Jul 2026) | 0.64B | 6.89 | 0.62B | 0.64B | 2 |
| FQ2 2026 (Jun 2026) | 0.64B | -3.65 | 0.62B | 0.64B | 3 |
| FQ1 2026 (Mar 2026) | 0.58B | -1.22 | 0.57B | 0.59B | 3 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.71 | 0.54 | -1.17 | -216.67% |
| FQ2 2025 (Jun 2025) | 1.71 | 1.17 | -0.54 | -46.15% |
| FQ1 2025 (Mar 2025) | 0.97 | 1.05 | 0.08 | 7.62% |
| FQ4 2024 (Dec 2024) | 1.21 | 1.21 | 100% | |
| FQ3 2024 (Sep 2024) | 1.04 | 1.04 | 100% | |
| FQ2 2024 (Jun 2024) | 2.162 | 2.162 | 100% | |
| FQ1 2024 (Mar 2024) | 0.72 | 0.72 | 100% | |
| FQ4 2023 (Dec 2023) | 2.38 | 2.38 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.62B | $0.59B | $-31.33M | -5.29% |
| FQ2 2025 (Jun 2025) | $0.62B | $0.66B | $42.6M | 6.46% |
| FQ1 2025 (Mar 2025) | $0.56B | $0.59B | $29.65M | 5.05% |
| FQ4 2024 (Dec 2024) | $0B | $0.65B | $647.63M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.55B | $549.96M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.61B | $613.29M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.53B | $528.35M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.63B | $633.06M | 100% |